Aspirin, clopidogrel and prasugrel monotherapy in patients with type 2 diabetes mellitus: a double-blind randomised controlled trial of the effects on thrombotic markers and microRNA levels
Parker W, Schulte C, Barwari T, Phoenix F, Pearson S, Mayr M, Grant P, Storey R, Ajjan R
CARDIOVASC DIABETOL. 2020;19(1):3.

Noncoding RNAs versus Protein Biomarkers in Cardiovascular Disease
Schulte C, Barwari T, Joshi A, Zeller T, Mayr M
TRENDS MOL MED. 2020;26(6):583-596.

Biomarker in der Primärprävention: Aussagekräftige Diagnose anhand von Biomarkerwerten?
Schulte C, Zeller T
HERZ. 2020;45(1):10-16.

Biomarkers for Heart Failure Prognosis: Proteins, Genetic Scores and Non-coding RNAs
Shrivastava A, Haase T, Zeller T, Schulte C
Front Cardiovasc Med. 2020;7:601364.

Comparative Analysis of Circulating Non-Coding RNAs Versus Protein Biomarkers in the Detection of Myocardial Injury
Schulte C, Barwari T, Joshi A, Theofilatos K, Zampetaki A, Barallobre-Barreiro J, Singh B, Sörensen N, Neumann J, Zeller T, Westermann D, Blankenberg S, Marber M, Liebetrau C, Mayr M
CIRC RES. 2019;125(3):328-340.

Response by Schulte et al to Letter Regarding Article, "Comparative Analysis of Circulating Noncoding RNAs Versus Protein Biomarkers in the Detection of Myocardial Injury"
Schulte C, Joshi A, Mayr M
CIRC RES. 2019;125(4):e22-e23.

MicroRNAs: A New Understanding of Platelet Physiology and Pathology
Schulte C, Mayr M
THROMB HAEMOSTASIS. 2019;119(2):191.

Inhibition of profibrotic microRNA-21 affects platelets and their releasate
Barwari T, Eminaga S, Mayr U, Lu R, Armstrong P, Chan M, Sahraei M, Fernández-Fuertes M, Moreau T, Barallobre-Barreiro J, Lynch M, Yin X, Schulte C, Baig F, Pechlaner R, Langley S, Zampetaki A, Santer P, Weger M, Plasenzotti R, Schosserer M, Grillari J, Kiechl S, Willeit J, Shah A, Ghevaert C, Warner T, Fernández-Hernando C, Suárez Y, Mayr M
JCI Insight. 2018;3(21):.

De-escalation of support with veno-arterial extracorporeal membrane oxygenation and Impella for cardiogenic shock: reply
Schulte C, Schrage B, Pappalardo F, Westermann D
EUR J HEART FAIL. 2018;20(3):622-623.

Circulating microRNAs strongly predict cardiovascular death in patients with coronary artery disease-results from the large AtheroGene study
Karakas M, Schulte C, Appelbaum S, Ojeda Echevarria F, Lackner K, Münzel T, Schnabel R, Blankenberg S, Zeller T
EUR HEART J. 2017;38(7):516-523.

Concomitant implantation of Impella(®) on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock
Pappalardo F, Schulte C, Pieri M, Schrage B, Contri R, Soeffker G, Greco T, Lembo R, Müllerleile K, Colombo A, Sydow K, De Bonis M, Wagner F, Reichenspurner H, Blankenberg S, Zangrillo A, Westermann D
EUR J HEART FAIL. 2017;19(3):404-412.

microRNAs in cardiovascular disease - clinical application
Schulte C, Karakas M, Zeller T
CLIN CHEM LAB MED. 2017;55(5):687-704.

miRNA-197 and miRNA-223 Predict Cardiovascular Death in a Cohort of Patients with Symptomatic Coronary Artery Disease
Schulte C, Molz S, Appelbaum S, Karakas M, Ojeda Echevarria F, Lau D, Hartmann T, Lackner K, Westermann D, Schnabel R, Blankenberg S, Zeller T
PLOS One. 2015;10(12):e0145930.

Diagnostic and prognostic value of circulating microRNAs in heart failure with preserved and reduced ejection fraction
Schulte C, Westermann D, Blankenberg S, Zeller T
World J Cardiol. 2015;7(12):843-60.

microRNA-based diagnostics and therapy in cardiovascular disease-Summing up the facts
Schulte C, Zeller T
Cardiovasc Diagn Ther. 2015;5(1):17-36.

Letzte Aktualisierung aus dem FIS: 22.03.2023 - 00:32 Uhr